041910 — Polaris AI Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Polaris AI Pharma, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	50,991	30,590	27,454	46,691	43,868
Net Total Accounts Receivable
Net Total Receivables	15,444	14,837	16,273	14,317	15,187
Total Inventory
Prepaid Expenses
Total Current Assets	84,164	67,731	64,342	78,217	75,446
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	31,306	31,138	30,592	30,007	28,532
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	134,361	124,319	121,899	134,451	195,929
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	9,037	7,036	4,871	4,717	28,853
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	11,062	8,230	6,266	5,868	60,002
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	123,299	116,089	115,633	128,583	135,927
Total Liabilities & Shareholders' Equity	134,361	124,319	121,899	134,451	195,929
Total Common Shares Outstanding